Atlas Trials

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

Clinical trial NCT06747455 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06747455
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
BCG
Start date
2025-04-08
Primary completion
2028-04-30
Enrollment
439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.